CN111494574A - Traditional Chinese medicine composition for treating cellulitis - Google Patents
Traditional Chinese medicine composition for treating cellulitis Download PDFInfo
- Publication number
- CN111494574A CN111494574A CN202010464297.2A CN202010464297A CN111494574A CN 111494574 A CN111494574 A CN 111494574A CN 202010464297 A CN202010464297 A CN 202010464297A CN 111494574 A CN111494574 A CN 111494574A
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- chinese medicine
- cellulitis
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 35
- 206010007882 Cellulitis Diseases 0.000 title claims abstract description 22
- 239000000203 mixture Substances 0.000 title claims abstract description 19
- 241000209035 Ilex Species 0.000 claims abstract description 6
- 235000003332 Ilex aquifolium Nutrition 0.000 claims abstract description 6
- 235000002296 Ilex sandwicensis Nutrition 0.000 claims abstract description 6
- 235000002294 Ilex volkensiana Nutrition 0.000 claims abstract description 6
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 229940079593 drug Drugs 0.000 claims abstract description 5
- 241001533088 Hypericum ascyron Species 0.000 claims abstract description 3
- 241001139545 Mallotus apelta Species 0.000 claims abstract description 3
- 235000000485 Smilax china Nutrition 0.000 claims abstract description 3
- 239000007788 liquid Substances 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 4
- 241001558017 Gynura Species 0.000 claims description 3
- 240000009022 Smilax rotundifolia Species 0.000 claims description 3
- 235000003205 Smilax rotundifolia Nutrition 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- 241000605422 Asparagus asparagoides Species 0.000 claims description 2
- 244000261559 Smilax china Species 0.000 claims description 2
- 241001404789 Smilax glabra Species 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 6
- 231100000419 toxicity Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- 230000008961 swelling Effects 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- 206010000269 abscess Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000362909 Smilax <beetle> Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000004159 blood analysis Methods 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 238000000643 oven drying Methods 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/90—Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition for treating cellulitis, which is prepared from the following raw material medicines in parts by weight: 5-10 parts of Mallotus apelta, 5-10 parts of Hypericum ascyron, 10-20 parts of ovateleaf holly bark and 15-30 parts of smilax china root; 30-60 parts of rhizoma smilacis glabrae.
Description
Technical Field
The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine composition for treating cellulitis.
Background
Cellulitis refers to a generalized, diffuse, suppurative inflammation of the skin and subcutaneous tissue caused by staphylococcus aureus, hemolytic streptococcus, or saprophytic bacteria.
The western medicine adopts large dose of antibiotics for treatment, and pain-relieving and antipyretic drugs are added when necessary. When in useAbscess and abscess of boneAfter the formation, incision for drainage and daily dressing change are required. Patients should be nourished and take multiple vitamins orally.
At present, no specific medicine for treating cellulitis exists.
Disclosure of Invention
The invention aims to improve the defects of the prior art and provide the traditional Chinese medicine composition for treating cellulitis, which can effectively improve or even eliminate the clinical symptoms of patients and has the characteristics of obvious treatment effect, short treatment period, no toxic or side effect and the like.
Cellulitis is equivalent to the category of "hairy" or "deep-rooted carbuncle" in traditional Chinese medicine. The traditional Chinese medicine considers that the dampness is accumulated. Therefore, when the antibacterial medicine is used for treatment, the Chinese patent medicine for clearing heat, removing toxicity, relieving swelling, expelling pus, inhibiting bacteria, diminishing inflammation, preventing corrosion and relieving itching is taken as an auxiliary medicine, so that the medicine is taken as a symptomatic medicine and is very beneficial to the recovery of the state of an illness.
The invention provides a traditional Chinese medicine composition for treating cellulitis, which comprises the following raw material medicines in parts by weight: 5-10 parts of Mallotus apelta, 5-10 parts of Hypericum ascyron, 10-20 parts of ovateleaf holly bark and 15-30 parts of smilax china root; 30-60 parts of rhizoma smilacis glabrae.
In a preferred embodiment, the traditional Chinese medicine composition for treating cellulitis consists of the following raw material medicines in parts by weight: 10 parts of gynura divaricata, 10 parts of herba ecliptae, 20 parts of ovate leaf holly bark and 30 parts of smilax root; 60 parts of glabrous greenbrier rhizome.
Wherein, the ovate leaf holly bark: bitter and cool. Clear heat and remove toxicity, relieve swelling and alleviate pain. It is suitable for suppurative diseases such as skin sore and furuncle, cellulitis, and deep abscess.
Leaf of divaricate Gynura: is bitter in taste; neutral nature is liver-qi-entering; spleen meridian. Clearing away heat; detoxification; eliminating dampness; stopping bleeding. Used for cellulitis, etc.
Smilax root: sweet, sour and neutral. Dispel wind, induce diuresis, remove toxicity and relieve swelling. Treating cellulitis, etc.
And (3) herba Hyperici Japonici: bitter; is cold. It enters liver meridian. Cooling blood to stop bleeding; promoting blood circulation to regulate menstruation; clearing away heat and toxic material, and expelling pus.
Glabrous greenbrier rhizome: sweet, bland and mild in taste. It enters liver and stomach meridians. Clear heat and remove toxicity, remove dampness, and dredge joints.
The traditional Chinese medicine composition is prepared from traditional Chinese herbal medicines, and is a traditional Chinese medicine composition for effectively treating cellulitis, which is formed by orderly matching certain natural extracts with definite components and clear effects.
The invention can run through the whole process of treating the cellulitis, treats both principal and secondary aspects of diseases, is not easy to relapse, is safe and reliable, has no obvious toxic and side effects, is convenient for patients to insist on taking for a long time, has no adverse reaction for the patients after taking the medicine for years, and tracks the normal blood examination.
The traditional Chinese medicine composition has the advantages of easily available raw materials, simple process, low cost and high efficiency, and is beneficial to pharmaceutical enterprises for medicine production and quality control; the product has low price and is easy to be accepted by patients.
The traditional Chinese medicine composition has a remarkable effect of treating cellulitis, and clinical experiment results show that the traditional Chinese medicine composition is used for treating cellulitis, one dose of the traditional Chinese medicine composition is taken every day, the traditional Chinese medicine composition is decocted with 100 ml of water and divided into two parts, one part is taken in the morning and at night, one month is taken as a treatment course, the effect is achieved in one treatment course, the three treatment courses are obviously improved, and the functions of the six treatment courses are basically cured. The cure rate is 90 percent, and the total effective rate is 100 percent.
The invention also provides an oral preparation prepared from the traditional Chinese medicine composition for treating cellulitis, wherein the oral preparation comprises oral liquid, tablets, capsules, pills and the like, preferably the dosage forms are tablets and capsules, and one dose is taken every day in the morning and at night.
The traditional Chinese medicine composition can be prepared into various dosage forms. For example, the decocted liquid medicine is sterilized and disinfected and then packaged to prepare oral liquid; or concentrating the decoction, oven drying, adding pharmaceutically acceptable adjuvants, and making into tablet, capsule, pill, etc.
The medically acceptable auxiliary materials comprise starch, dextrin, sodium carboxymethylcellulose, polyethylene glycol, calcium hydrophosphate, sodium alginate, potassium sorbate and the like.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the present invention in any way, and it will be apparent to those skilled in the art that the above description of the present invention can be applied to various modifications, equivalent variations or modifications without departing from the spirit and scope of the present invention.
Claims (4)
1. A traditional Chinese medicine composition for treating cellulitis is characterized by comprising the following raw material medicines in parts by weight: 5-10 parts of Mallotus apelta, 5-10 parts of Hypericum ascyron, 10-20 parts of ovateleaf holly bark and 15-30 parts of smilax china root; 30-60 parts of rhizoma smilacis glabrae.
2. The traditional Chinese medicine composition for treating cellulitis according to claim 1, which is characterized by consisting of the following raw material medicines in parts by weight: 10 parts of gynura divaricata, 10 parts of herba ecliptae, 20 parts of ovate leaf holly bark and 15-30 parts of smilax root; 60 parts of glabrous greenbrier rhizome.
3. An oral preparation for treating cellulitis, which is prepared from the Chinese medicinal composition according to any one of claims 1 or 2.
4. The cellulitis oral preparation according to claim 3, which comprises oral liquid, tablet, capsule, pill, preferably oral liquid and tablet.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010464297.2A CN111494574A (en) | 2020-05-28 | 2020-05-28 | Traditional Chinese medicine composition for treating cellulitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010464297.2A CN111494574A (en) | 2020-05-28 | 2020-05-28 | Traditional Chinese medicine composition for treating cellulitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111494574A true CN111494574A (en) | 2020-08-07 |
Family
ID=71878692
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010464297.2A Pending CN111494574A (en) | 2020-05-28 | 2020-05-28 | Traditional Chinese medicine composition for treating cellulitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111494574A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111803568A (en) * | 2020-08-09 | 2020-10-23 | 仲崇允 | Traditional Chinese medicine external preparation for treating cellulitis |
-
2020
- 2020-05-28 CN CN202010464297.2A patent/CN111494574A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111803568A (en) * | 2020-08-09 | 2020-10-23 | 仲崇允 | Traditional Chinese medicine external preparation for treating cellulitis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101791378B (en) | Traditional Chinese medicine preparation for wound hemostasis, anti-inflammatory and tissue regeneration | |
| CN111494574A (en) | Traditional Chinese medicine composition for treating cellulitis | |
| CN104274619A (en) | Externally-applied pharmaceutical composition for preventing and treating cow mastitis and preparation method of externally-applied pharmaceutical composition | |
| CN104547936A (en) | Traditional Chinese medicine for treating local induration of vascular access of hemodialysis patient | |
| CN112933173A (en) | Traditional Chinese medicine composition for treating prostatitis | |
| CN113181258A (en) | A Chinese medicinal composition for treating menoxenia, dysmenorrhea, and amenorrhea | |
| CN102671036B (en) | Traditional Chinese medicine oral liquid for treating chronic lung abscess and preparing method thereof | |
| CN111529665A (en) | A Chinese medicinal composition for treating angiitis and varicosis | |
| CN105267678B (en) | Chinese medicine composition for mandibular osteomyelitis | |
| CN113304218B (en) | Traditional Chinese medicine for treating feline calicivirus infection | |
| CN111759936A (en) | A Chinese medicinal composition for treating dermatoses | |
| CN108245577B (en) | Ointment for relieving pain, eliminating swelling and promoting tissue regeneration of burn and preparation method thereof | |
| CN111759908A (en) | Traditional Chinese medicine composition for treating urticaria | |
| CN105012443A (en) | Traditional Chinese medicine for treating gastritis | |
| CN111588782A (en) | A Chinese medicinal composition for treating osteomyelitis and bone tuberculosis | |
| CN111714601A (en) | A Chinese medicinal composition for treating fungal infection | |
| CN113476576A (en) | Traditional Chinese medicine composition for treating pyelonephritis | |
| CN111588751A (en) | A Chinese medicinal composition for treating acute gastroenteritis and dysentery | |
| CN113694118A (en) | Traditional Chinese medicine composition for treating mastitis | |
| CN111419969A (en) | Traditional Chinese medicine composition for treating osteomyelitis | |
| CN111714548A (en) | Traditional Chinese medicine composition for treating cervicitis | |
| CN104887863A (en) | Lingual tonsilitis treatment traditional Chinese medicine spray and preparation method thereof | |
| CN111419921A (en) | Traditional Chinese medicine composition for treating acne, carbuncle and furuncle | |
| CN111588817A (en) | Traditional Chinese medicine composition for treating vomiting of pregnancy | |
| CN111759960A (en) | Traditional Chinese medicine composition for miscarriage prevention |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20200807 |